Results 201 to 210 of about 200,214 (356)

Targeting autophagy and plasminogen activator inhibitor-1 increases survival and remodels the tumor microenvironment in glioblastoma. [PDF]

J Exp Clin Cancer Res
Shifman SG, O'Connor JL, Radin DP, Sharma A, Infante L, Ferraresso F, Kastrup CJ, Lawrence DA, Tsirka SE.   +8 more
europepmc   +1 more source

Mechanism of the urokinase-catalyzed activation of human plasminogen.

, 1976
Bernard N. Violand, Francis Castellino
openalex   +1 more source

Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor. [PDF]

, 1988
Toni Antalis, Marta A. Clark, Tristan S. Barnes, P R Lehrbach, Peter L. Devine, Galina Schevzov, Neil H. Goss, Ross W. Stephens, Paul Tolstoshev   +8 more
openalex   +1 more source

Principal mechanisms of extracellular matrix‐mediated cell–cell communication in physiological and tumor microenvironments

The FEBS Journal, EarlyView.
Intracellular communication controls the processing of generated signals so that every cell type can successfully respond. The extracellular matrix (ECM) is a fundamental regulator of cell communication and signaling through the strict orchestration and functions of its bioactive components.
Zoi Piperigkou, Sylvia Mangani, Nikolaos E. Koletsis, Christos Koutsakis, Nicholas S. Mastronikolis, Marco Franchi, Nikos K. Karamanos   +6 more
wiley   +1 more source

Soluble Urokinase Plasminogen Activator Receptor Predicts Survival and Hepatic Decompensation in Advanced Hepatocellular Carcinoma. [PDF]

Liver Int
Artusa F, Lamatsch S, Phan MD, Özdirik B, Berger H, Egerer M, Knorr-Klocke J, Fischer J, Veelken R, van Bömmel F, Berg T, Kappert K, Tauber R, Puengel T, Engelmann C, Demir M, Tacke F, Mohr R.   +17 more
europepmc   +1 more source

Estimating the Factor VIII‐Equivalent Activity of Emicizumab Using Global Assays of Haemostasis

Haemophilia, EarlyView.
ABSTRACT Background Emicizumab is a bispecific monoclonal antibody mimicking factor (F) VIII activity and an effective therapy for prophylaxis in people with haemophilia A (PWHA). The FVIII‐equivalent activity (FVIIIeq) of emicizumab remains unknown. Objectives To estimate FVIIIeq of emicizumab using global assays of haemostasis.
Daniel Kraemmer, Cihan Ay, Judit Rejtő, Georg Heinze, Peter Quehenberger, Ingrid Pabinger, Oliver Königsbrügge   +6 more
wiley   +1 more source

Imaging efficacy and safety of low dose intraventricular tissue plasminogen activator in aneurysmal subarachnoid hemorrhage: case series. [PDF]

Acta Neurochir (Wien)
Liu C, Wroe WW, Zeineddine HA, Dawes B, Giordano M, McCabe A, Chen CJ, McBride DW, Gusdon AM, Choi HA, Blackburn SL.   +10 more
europepmc   +1 more source

Mechanism of dexamethasone inhibition of plasminogen activator in rat hepatoma cells.

, 1978
Stefan Seifert, Thomas Gelehrter
openalex   +1 more source

Cerebrospinal fluid and serum biomarkers in idiopathic intracranial hypertension: A systematic review

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective This study aimed to systematically review the literature on soluble biomarkers in adults with idiopathic intracranial hypertension (IIH). Background Idiopathic intracranial hypertension is a multifactorial disorder marked by elevated intracranial pressure without a clear cause.
Marina Romozzi, Fabio Zeoli, Renata Martinelli, Federico Tosto, Antonio Funcis, Giuseppe Garignano, Sabrina Chiloiro, Lucia Di Nardo, Catello Vollono, Alessandro Olivi, Paolo Calabresi, Francesco Signorelli   +11 more
wiley   +1 more source

Tissue plasminogen activator modified thromboelastography identifies fibrinolysis resistance in dogs with immune-mediated hemolytic anemia. [PDF]

Front Vet Sci
Goggs R, Davis S, Brooks MB.
europepmc   +1 more source